Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shanghai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Guizhou Yibai Pharmaceutical Co Ltd

+ Add to Watchlist

600594:CH

60.950 CNY 3.310 5.15%

As of 03:05:16 ET on 05/28/2015.

Snapshot for Guizhou Yibai Pharmaceutical Co Ltd (600594)

Open: 64.400 Day's Range: 60.000 - 67.050 Volume: 9,123,613
Previous Close: 64.260 52wk Range: 30.990 - 67.050 1-Yr Rtn: +52.87%

Stock Chart for 600594

No chart data available.
  • 600594:CH 61.000
  • 1D
  • 1M
  • 1Y
64.260
Interactive 600594 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 600594

Current P/E Ratio (ttm) 49.9795
Estimated P/E(12/2015) 36.9394
Relative P/E vs. SHASHR 2.1798
Earnings Per Share (CNY) (ttm) 1.2195
Est. EPS (CNY) (12/2015) 1.6500
Est. PEG Ratio -
Market Cap (M CNY) 24,133.99
Shares Outstanding (M) 395.96
30 Day Average Volume 8,707,738
Price/Book (mrq) 6.9189
Price/Sale (ttm) 7.6163
Dividend Indicated Gross Yield 0.20%
Cash Dividend (CNY) 0.1200
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600594

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 600594

Guizhou Yibai Pharmaceutical Co., Ltd. manufactures Chinese traditional medicines that are used for the treatment of cough, tumor, and cardiovascular diseases.

Dou QilingChairman/PresidentLang HongpingVice President
Dou YaqiVice PresidentZhang ShengguiVP/Marketing Director
More Company Profile & Key Executives for 600594

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil